Non-ownership Filings
FDA Grants Fast Track Designation for Bexmarilimab | Aug. 27, 2024 |
Faron 2024 Half-Year Financial Results | Aug. 27, 2024 |
Notice of Half-Year Financial Results | Aug. 20, 2024 |
Traumakine Research Collaboration and DoD Grant | Aug. 13, 2024 |
Appointment of Chief Financial Officer | Aug. 08, 2024 |
Faron Appoints Dr. Petri Bono as new CMO | Aug. 06, 2024 |
Faron Announces Positive FDA Feedback | Jul. 11, 2024 |
Ownership Update Filings
Grant of options | Aug. 30, 2024 |
Grant of options | Aug. 07, 2024 |
Holding(s) in Company - Replacement | Jun. 25, 2024 |
Announcement of Placing | Apr. 04, 2024 |
Grant of options | Dec. 04, 2023 |
Manager's transactions | Oct. 27, 2023 |
Exercise of options | Aug. 31, 2023 |